-+ 0.00%
-+ 0.00%
-+ 0.00%

INCYTE JAPAN ANNOUNCES APPROVAL OF MINJUVI® (TAFASITAMAB) IN COMBINATION WITH RITUXIMAB AND LENALIDOMIDE FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

路透·12/22/2025 07:44:00

登录查看新闻详情